Halozyme
HALO
HALO
132 hedge funds and large institutions have $882M invested in Halozyme in 2014 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 43 increasing their positions, 36 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
9% more capital invested
Capital invested by funds: $810M → $882M (+$72.4M)
34% less call options, than puts
Call options by funds: $8.6M | Put options by funds: $13M
Holders
132
Holding in Top 10
4
Calls
$8.6M
Puts
$13M
Top Buyers
| 1 | +$11.6M | |
| 2 | +$7.32M | |
| 3 | +$4.39M | |
| 4 |
Millennium Management
New York
|
+$3.99M |
| 5 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$3.81M |
Top Sellers
| 1 | -$19.7M | |
| 2 | -$8.05M | |
| 3 | -$2.81M | |
| 4 |
HCM
Harvey Capital Management
Palm Beach,
Florida
|
-$2.6M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$1.79M |